Splenic Vein Leiomyosarcoma: Case Report and Review of the Literature
Abstract
Context Primary venous leiomyosarcoma (LMS) is a rare disease, most commonly affecting the retroperitoneal veins and in particular the inferior vena cava. Five-year survival rate ranges between 33% and 68%. Case Report Complete surgical resection represents the only potentially curative treatment, occasionally achieving long-term survival. LMS of the splenic vein is extremely rare, with only three cases reported in the literature. Conclusion We report a case of primary venous LMS arising from the splenic vein and we briefly review the relevant literature.
Image: Intraoperative snapshot.
Downloads
References
Ceyhan M, Danaci M, Elmali M, Ozmen Z. Leiomyosarcoma of the inferior vena cava. Diagnostic and interventional radiology. 2007; 13: 140-143. [PMID: 17846988].
Hollenbeck ST, Grobmyer SR, Kent KC, Brennan MF. Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. Journal of the American College of Surgeons. 2003; 197: 575-579. [PMID: 14522326].
Aguilar C, Socola F, Donet JA, Gallastegui N, Hernandez GA. Leiomyosarcoma of the splenic vein. Clinical Medicine Insights Oncology. 2013; 7: 263-268. [PMID: 24250242].
Gage MJ, Newman E, Maldonado TS, Hajdu CH. Leiomyosarcoma of the splenic vein. Journal of vascular surgery. 2012; 55: 1485-1487. [PMID: 22051866].
Niver BE, Megibow AJ, Faust MJ, Rosenkrantz AB. Multidetector CT appearance of leiomyosarcoma of the splenic vein. Clinical radiology. 2011; 66: 688-690. [PMID: 21356533].
Rodl W, Hofmann-Preiss K. [Leiomyosarcoma of the splenic vein]. Radiologe. 1988; 28: 42-44. [PMID: 3344346].
Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997; 15: 350-362. [PMID: 8996162].
Miettinen M. Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers. Histopathology. 2014; 64: 101-118. [PMID: 24111893].
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005; 138: 8-13. [PMID: 16003309].
Mingoli A, Cavallaro A, Sapienza P, Di Marzo L, Feldhaus RJ, Cavallari N. International registry of inferior vena cava leiomyosarcoma: analysis of a world series on 218 patients. Anticancer research. 1996; 16: 3201-3205. [PMID: 8920790].
Dzsinich C, Gloviczki P, van Heerden JA, Nagorney DM, Pairolero PC, Johnson CM, et al. Primary venous leiomyosarcoma: a rare but lethal disease. Journal of vascular surgery. 1992; 15: 595-603. [PMID: 1560548].
Hines OJ, Nelson S, Quinones-Baldrich WJ, Eilber FR. Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer. 1999; 85: 1077-1083. [PMID: 10091791].
Kieffer E, Alaoui M, Piette JC, Cacoub P, Chiche L. Leiomyosarcoma of the inferior vena cava: experience in 22 cases. Annals of surgery. 2006; 244: 289-295. [PMID: 16858193].
Kyriazi MA, Stafyla VK, Chatzinikolaou I, Koureas A, Chatziioannou A, Kondi-Paphiti A, et al. Surgical challenges in the treatment of leiomyosarcoma of the inferior vena cava: analysis of two cases and brief review of the literature. Annals of vascular surgery. 2010; 24: 826 e13-17. [PMID: 20471215].
Laskin WB, Fanburg-Smith JC, Burke AP, Kraszewska E, Fetsch JF, Miettinen M. Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases. The American journal of surgical pathology. 2010; 34: 873-881. [PMID: 20463568].
Tilkorn DJ, Hauser J, Ring A, Goertz O, Stricker I, Steinau HU, et al. Leiomyosarcoma of intravascular origin--a rare tumor entity: clinical pathological study of twelve cases. World journal of surgical oncology. 2010; 8: 103. [PMID: 21092216].
Copyright (c) 2014 Damiano Patrono, Luca Molinaro, Elena Mazza, Renato Romagnoli, Mauro Salizzoni
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.